The effect of COVID-19 on pain control in patients with a neurostimulator in situ- a retrospective study
ConclusionsInfection with SARS-CoV-2, in a significant proportion of patients with an SCS in situ, causes at least a transient deterioration in pain control. Further prospective multicentre studies are indicated to establish the prevalence of this phenomenon.
Source: Acta Neurochirurgica - Category: Neurosurgery Source Type: research
More News: Back Pain | Brain | Chronic Pain | COVID-19 | Neurology | Neurosurgery | Pain | SARS | Study